Thai healthtech company HD has revealed plans to enter Vietnam after receiving a significant investment from Vietnamese venture capital firm FEBE Ventures.

As the impact of the Covid-19 pandemic gradually fades, healthtech companies in Southeast Asia have consistently been able to attract substantial funding. Its new investment will help HD expand its presence in other markets in the region, especially in Vietnam, where the company sees great opportunities for surgical and healthcare solutions.

HD was founded in 2019 and has since met the healthcare needs of over 250,000 patients. It provides healthcare services to both outpatients and inpatients through HDmall, available in Thailand and Indonesia. This platform connects patients with over 1,500 healthcare service providers.

In January, HD successfully raised $6 million in a funding round from investors such as AC Ventures and M Venture Partners. The Thai-based company aims to be profitable by the end of this year.

The company launched HDcare last November, which allows healthcare providers to utilize their operating rooms more efficiently while helping patients access surgeries faster.

HD revealed that patient demand for the service has increased 30-fold since the introduction of HDcare.